High Tech Pharm하이텍팜
106190 · KOSDAQ · ₩106190 · 하이텍팜
₩8,980▲ ₩100 (1.13%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩70B | ₩78B | ₩77B | ₩103B | ₩73B |
| Cost of sales | ₩53B | ₩58B | ₩64B | ₩95B | ₩70B |
| Gross profit | ₩17B | ₩19B | ₩13B | ₩7.8B | ₩3.1B |
| Operating income | ₩13B | ₩16B | ₩10B | ₩4.9B | −₩412M |
| Net income | ₩11B | ₩14B | ₩8.1B | ₩5.9B | −₩1.2B |
| Net income to shareholders | ₩11B | ₩14B | ₩8.1B | ₩5.9B | −₩1.2B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩144B | ₩140B | ₩135B | ₩132B | ₩123B |
| Current assets | ₩71B | ₩64B | ₩57B | ₩52B | ₩40B |
| Cash and equivalents | ₩13B | ₩7.8B | ₩3.5B | ₩7.9B | ₩11B |
| Total liabilities | ₩13B | ₩20B | ₩28B | ₩32B | ₩29B |
| Current liabilities | ₩13B | ₩19B | ₩23B | ₩32B | ₩23B |
| Borrowings | ₩0 | ₩7.9B | ₩16B | ₩16B | ₩16B |
| Total equity | ₩131B | ₩120B | ₩107B | ₩100B | ₩94B |
| Shareholders' equity | ₩131B | ₩120B | ₩107B | ₩100B | ₩94B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩17B | ₩15B | ₩2.9B | −₩3.7B | ₩6.9B |
| Capital spending | ₩1.9B | ₩2.1B | ₩5.1B | ₩656M | ₩860M |
| Free cash flow | ₩15B | ₩13B | −₩2.2B | −₩4.4B | ₩6.1B |
| Dividends paid | ₩1.1B | ₩709M | ₩496M | ₩354M | ₩354M |
Consolidated where available. Amounts in won.
Also known as: High Tech Pharm / 하이텍팜 / 106190 / KRX:106190
Source: KRX statistical information